Home › Research › Lewy body dementia
A common outcome set for trials in dementia with Lewy bodies (DLB COS)
Joseph P. M. Kane, Rachel L. Fitzpatrick, Sara M. Betzhold, Gillian Daly, Emily Kalfas, Irina Kinchin, Dag Aarsland, Ken Greaney et al.. Alzheimer s & Dementia Translational Research & Clinical Interventions, 2025-07-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Forty-nine outcomes were presented to survey respondents. Consensus was reached regarding eight outcomes for the final DLB COS: delusions/paranoia; fluctuations in cognition, attention, and arousal; functioning; global cognition; hallucinations; quality of life; motor parkinsonism; and rapid eye movement sleep behavior disorder. If adopted, DLB COS can enhance the comparability of research findings and facilitate standardization and harmonization. Highlights: A systematic review revealed heterogeneity in dementia with Lewy bodies (DLB) study outcomes.Our study produced a DLB Core Outcome Set (DLB COS) comprising eight outcomes.DLB COS sets the minimum reporting standards for future trials.DLB-specific rating scales incorporating these outcomes are needed.Addressing this gap is a strategic priority in DLB research.
What this study adds
Evidence grade: High
This is a pooled review. This systematic review produced a dementia with Lewy bodies Core Outcome Set comprising eight outcomes to standardize reporting in future trials. It aims to enhance comparability of research findings but does not provide a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kane, J. P. M., Fitzpatrick, R. L., Betzhold, S. M., Daly, G., Kalfas, E., Kinchin, I., et al. (2025). A common outcome set for trials in dementia with Lewy bodies (DLB COS). Alzheimer s & Dementia Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70134
Vancouver
Kane JPM, Fitzpatrick RL, Betzhold SM, Daly G, Kalfas E, Kinchin I, et al. A common outcome set for trials in dementia with Lewy bodies (DLB COS). Alzheimer s & Dementia Translational Research & Clinical Interventions. 2025. doi:10.1002/trc2.70134. PMID: 40657378.
BibTeX
@article{kane2025-40657378,
author = {Kane, Joseph P. M. and Fitzpatrick, Rachel L. and Betzhold, Sara M. and Daly, Gillian and Kalfas, Emily and Kinchin, Irina and Aarsland, Dag and Greaney, Ken and others},
title = {{A common outcome set for trials in dementia with Lewy bodies (DLB COS)}},
journal = {Alzheimer s \& Dementia Translational Research \& Clinical Interventions},
year = {2025},
doi = {10.1002/trc2.70134},
pmid = {40657378},
url = {https://doi.org/10.1002/trc2.70134}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Forty-nine outcomes were presented to survey respondents.
- Consensus was reached regarding eight outcomes for the final DLB COS: delusions/paranoia; fluctuations in cognition, attention, and arousal; functioning; global cognition; hallucinations; quality of life; motor parkinsonism; and rapid eye movement sleep behavior disorder.
- If adopted, DLB COS can enhance the comparability of research findings and facilitate standardization and harmonization.
- Highlights: A systematic review revealed heterogeneity in dementia with Lewy bodies (DLB) study outcomes.Our study produced a DLB Core Outcome Set (DLB COS) comprising eight outcomes.DLB COS sets the minimum reporting standards for future trials.DLB-specific rating scales incorporating these outcomes are needed.Addressing this gap is a strategic priority in DLB research.
Why it matters
This systematic review produced a dementia with Lewy bodies Core Outcome Set comprising eight outcomes to standardize reporting in future trials. It aims to enhance comparability of research findings but does not provide a treatment or cure.
Study details
- Study designsystematic review
- Evidence strengthHigh
How this study scored 58/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 56 of the 96 points we could judge it on, which is 58 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Translational Research & Clinical Interventions) |
| Journal's citation record | 1 / 4 | Alzheimer s & Dementia Translational Research & Clinical Interventions: journal h-index 84 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 12.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 16 institution(s) in 5 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40657378) |
| Free to read | 2 / 2 | Free to read |
| Points | 56 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 56 of the 96 points we could judge it on is 58 out of 100. |
| Total | 58 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/trc2.70134
- PubMed: 40657378
- Original source →
- Free full text: Alzheimer s & Dementia Translational Research & Clinical Interventions →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Lewy body dementia from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.